Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
7.82%Return on Invested Capital
VS
Market
Sector
Industry
History
$ 9.87Close
$ 3.7 - $ 11.11 52-Week Range
Ticker Information
Ticker
GLUECompany Name
MONTE ROSA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQMONTE ROSA THERAPEUTICS INC - Return on Invested Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
GLUE - ROIC Historical data
| Date | Invested Capital | Net Income Common Stock | Return on Invested Capital |
|---|---|---|---|
| 6/30/2025 | $ 309.21M | $ 24.17M | 7.82% |
| 3/31/2025 | $ 317.02M | $ 6.15M | 1.94% |
| 12/31/2024 | $ 265.65M | $ -72.7M | -27.37% |
| 9/30/2024 | $ 249.16M | $ -119.39M | -47.92% |
| 6/30/2024 | $ 269.03M | $ -130.41M | -48.48% |
| 3/31/2024 | $ 197.7M | $ -135.28M | -68.43% |
| 12/31/2023 | $ 225.29M | $ -135.35M | -60.08% |
| 9/30/2023 | $ 230.92M | $ -132.88M | -57.54% |
| 6/30/2023 | $ 260.69M | $ -125.32M | -48.07% |
| 3/31/2023 | $ 289.89M | $ -116.61M | -40.22% |
Key Performance Insights, Last 5 Years
- MONTE ROSA THERAPEUTICS INC's latest trailing twelve months (TTM) ROIC stands at 0%.
- Over the past 5 years, MONTE ROSA THERAPEUTICS INC's average ROIC has been -35.08%.
- The median ROIC for MONTE ROSA THERAPEUTICS INC during this period was -34.08%
- MONTE ROSA THERAPEUTICS INC reached its highest ROIC over the past 5 years at 7.82%.
- The lowest ROIC recorded by MONTE ROSA THERAPEUTICS INC in the same timeframe -68.43%
MONTE ROSA THERAPEUTICS INC's ROIC vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROIC Benchmarks
Similar metrics to ROIC:
- Cash Return on Invested Capital - [Calculation] Cash Return on Invested Capital (CROIC) measures how well a company uses its invested capital to produce cash. It is calculated as Free Cash Flow [FCF] divided by invested capital [InvCapital].
- Invested Capital - [Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
Definition of Return on Invested Capital
[Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].Net Inc. Cmn. / Inv. Capital
(=) ROIC ROIC for MONTE ROSA THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -35.88M ] / Inv. Capital [ $ -48.73M ]
(=) ROIC [ 0% ] GLUE - Return on Invested Capital, Last 5 years
-68.43%
Minimum
Mar 31, 2024
7.82%
Maximum
Jun 30, 2025
-35.08%
Average
-34.08%
Median
ROIC Benchmark AnalysisMarket
The chart above depicts the distribution of ROIC for companies in the Total Stock Market. The average ROIC of the companies is 0.69% with a standard deviation of 15.18%.
The following table provides additional summary stats:
ROIC in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | -46.36% |
| max | 48.66% |
| average | 0.69% |
| median | 3.39% |
| std | 15.18% |